bolero-2 (afinitor and exemestane study) shows implications in er-positive breast cancer
Published 12 years ago • 1.4K plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
8:33
bolero-2 trial: everolimus in metastatic breast cancer
-
8:15
bolero-2: overcoming treatment resistance in breast cancer
-
1:25
dr. hortobagyi discusses the bolero-2 trial
-
2:56
everolimus in er-positive breast cancer
-
1:24
dr. perez discusses the bolero-2 everolimus trial
-
13:56
jose baselga, md, phd: bolero-2 findings confirm efficacy of everolimus plus exemestane
-
5:13
bolero-2
-
7:37
next steps for everolimus in er-positive metastatic breast cancer
-
2:46
combo boosts breast cancer survival in bolero-2
-
1:38
dr. baselga discusses the bolero breast cancer trials
-
3:51
everolimus in postmenopausal hormone-receptor--positive advanced breast cancer - the bolero-2 trial
-
5:45
real-world: efficacy of everolimus exemestane hr , her2- bc
-
1:11
results of trial of ribociclib with everolimus and exemestane in breast cancer
-
3:43
second-line everolimus in metastatic breast cancer
-
5:14
comment: bolero-1 reports her2-positive breast cancer latest pfs data
-
3:26
updates in er-positive breast cancer by debu tripathy, md
-
4:59
emcc 2011: prof jose baselga on the bolero-2 study
-
2:00
dr. yardley discusses the role of everolimus in breast cancer and the bolero trials
-
1:55
dr. kornblum on results of precog 0102 in breast cancer